20 December 2017
Dissemination of the R&D activity of the Medicinal Chemistry & Synthesis group in social media
The Medicinal Chemistry & Synthesis (MCS) research group from the Institute of Advanced Chemistry of Catalonia (IQAC, CSIC) focuses on therapeutic chemistry. MCS investigates the improvement and optimization of existing drugs, and it also develops new therapeutic approaches. Moreover, it offers specialised research support services to the public and private sectors. In fact, it is a candidate for TECNIO, a quality hallmark that ACCIÓ awards to those groups presenting a high knowledge transfer potential, and its members participated in our training and supporting sessions focused on the development of marketing plans.
In order to help them disseminate the results of their R&D activity, the MCS group requested our collaboration to launch a communication strategy on social networks and communication departments of related institutions.
As a result, in October and November we worked on the dissemination of new competitive projects obtained by MCS, new collaborations with international labs and also their participation on diverse meetings, seminars and specialised trade fairs. With more than 20 impacts achieved in these two months, we would like to encourage the MCS team to continue with the strategy to disseminate the high standard of research they carry out on a daily basis.
